Department of Endocrinology and Metabolism, The Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Affiliated Hospital of China Medical University, Shenyang, China.
Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang, China.
Thyroid. 2023 Jun;33(6):762-770. doi: 10.1089/thy.2022.0460. Epub 2023 May 8.
Gestational transient thyrotoxicosis (GTT) and Graves' disease (GD) are the most common causes of hyperthyroidism during pregnancy. However, few studies have compared pregnancy outcomes of patients who had GTT with those who had GD in the first trimester of pregnancy. We conducted a prospective multicenter cohort study in China. Participants received questionnaires, physical examinations, and underwent measurements of thyrotropin (TSH), free thyroxine (fT4), thyroid peroxidase antibody (TPOAb), TSH receptor antibody (TRAb), and urinary iodine in the first trimester. The patients diagnosed with either GTT or GD and normal thyroid function (NTF) group were followed until delivery. The thyroid function and pregnancy outcomes were reported. A total of 125 pregnant women with thyrotoxicosis and 246 age-matched pregnant women with NTF were included. (1) The thyroid function of the GTT group returned to normal range in the third trimester, but was consistently abnormal in the GD group. (2) The incidence of gestational diabetes mellitus (GDM) in the GTT group (11.5%, 9/78) was significantly higher than that in NTF group (4.9%, 12/246) ( = 0.037). The incidence of premature delivery in the GD untreated (30.8%, 8/26, = 0.002) and treated groups (28.6%, 6/21, = 0.008) was both, respectively, higher than that in the NTF group (7.7%, 19/246). Miscarriage (15.4%, 4/26 vs. 3.7%, 9/246, = 0.026) and gestational hypertension (19.2%, 5/26 vs. 3.3%, 8/246, = 0.004) were more prevalent in the GD untreated group than in the NTF group. (3) The presence of positive TRAb and positive TPOAb in the first trimester were independent risk factors for miscarriage (odds ratio [OR] = 5.23, confidence interval [CI] = 1.11-24.78, = 0.037) and low birth weight infants (OR = 7.76, CI = 1.23-48.86, = 0.029), respectively. In conclusion, pregnancy outcomes appear variable, according to the etiology of first trimester thyrotoxicosis. GTT appears to be associated with GDM. GD appears to be associated with an increased risk of premature delivery, gestational hypertension, and miscarriage. The diagnosis of GTT and GD patients during early pregnancy and appropriate treatment of GD patients may be associated with improved pregnancy outcomes.
妊娠一过性甲状腺毒症(GTT)和 Graves 病(GD)是妊娠期间甲状腺功能亢进最常见的原因。然而,很少有研究比较过妊娠早期 GTT 患者和 GD 患者的妊娠结局。
我们在中国进行了一项前瞻性多中心队列研究。参与者在妊娠早期接受了问卷调查、体格检查,并进行了促甲状腺激素(TSH)、游离甲状腺素(fT4)、甲状腺过氧化物酶抗体(TPOAb)、促甲状腺激素受体抗体(TRAb)和尿碘的检测。诊断为 GTT 或 GD 且甲状腺功能正常(NTF)的患者被随访至分娩。报告了甲状腺功能和妊娠结局。
共纳入 125 例甲状腺毒症孕妇和 246 例年龄匹配的 NTF 孕妇。(1)GTT 组的甲状腺功能在孕晚期恢复正常范围,但 GD 组的甲状腺功能一直异常。(2)GTT 组(11.5%,9/78)妊娠期糖尿病(GDM)的发生率明显高于 NTF 组(4.9%,12/246)(=0.037)。未治疗的 GD 组(30.8%,8/26)和治疗组(28.6%,6/21)的早产发生率均高于 NTF 组(7.7%,19/246)。流产(15.4%,4/26 比 3.7%,9/246,=0.026)和妊娠期高血压(19.2%,5/26 比 3.3%,8/246,=0.004)在未治疗的 GD 组更为常见。(3)孕早期存在阳性 TRAb 和阳性 TPOAb 是流产(比值比 [OR] = 5.23,置信区间 [CI] = 1.11-24.78,=0.037)和低出生体重儿(OR = 7.76,CI = 1.23-48.86,=0.029)的独立危险因素。
总之,根据妊娠早期甲状腺毒症的病因,妊娠结局似乎各不相同。GTT 似乎与 GDM 有关。GD 似乎与早产、妊娠期高血压和流产的风险增加有关。在妊娠早期诊断 GTT 和 GD 患者并对 GD 患者进行适当治疗可能与改善妊娠结局有关。